Adaptimmune Therapeutics PLC (ADAP)
1.09
-0.03
(-2.68%)
USD |
NASDAQ |
Apr 24, 10:58
Adaptimmune Therapeutics 1 Year Total Returns (Daily): -17.04% for April 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 23, 2024 | -17.04% |
April 22, 2024 | -25.19% |
April 19, 2024 | -35.32% |
April 18, 2024 | -33.45% |
April 17, 2024 | -28.99% |
April 16, 2024 | -24.26% |
April 15, 2024 | -22.79% |
April 12, 2024 | -2.52% |
April 11, 2024 | 6.61% |
April 10, 2024 | 12.39% |
April 09, 2024 | 26.85% |
April 08, 2024 | 25.93% |
April 05, 2024 | 30.48% |
April 04, 2024 | 31.07% |
April 03, 2024 | 30.19% |
April 02, 2024 | 28.44% |
April 01, 2024 | 34.86% |
March 28, 2024 | 49.06% |
March 27, 2024 | 43.64% |
March 26, 2024 | 38.18% |
March 25, 2024 | 30.91% |
March 22, 2024 | 29.73% |
March 21, 2024 | 12.60% |
March 20, 2024 | 22.02% |
March 19, 2024 | 25.89% |
Date | Value |
---|---|
March 18, 2024 | 31.25% |
March 15, 2024 | 30.97% |
March 14, 2024 | 26.96% |
March 13, 2024 | 43.24% |
March 12, 2024 | 33.04% |
March 11, 2024 | 37.50% |
March 08, 2024 | 45.83% |
March 07, 2024 | 39.20% |
March 06, 2024 | 29.55% |
March 05, 2024 | -17.05% |
March 04, 2024 | -15.91% |
March 01, 2024 | -3.64% |
February 29, 2024 | -11.30% |
February 28, 2024 | -9.04% |
February 27, 2024 | -6.04% |
February 26, 2024 | -3.53% |
February 23, 2024 | -8.64% |
February 22, 2024 | -14.81% |
February 21, 2024 | -4.46% |
February 20, 2024 | -26.32% |
February 16, 2024 | -29.82% |
February 15, 2024 | -24.24% |
February 14, 2024 | -22.89% |
February 13, 2024 | -22.90% |
February 12, 2024 | -26.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.35%
Minimum
Oct 08 2019
767.9%
Maximum
Oct 13 2020
8.56%
Average
-44.84%
Median
Feb 16 2023
1 Year Total Returns (Daily) Benchmarks
Biodexa Pharmaceuticals Plc | -96.32% |
NuCana PLC | -82.98% |
Autolus Therapeutics PLC | 148.9% |
Mereo BioPharma Group PLC | 180.8% |
TC BioPharm (Holdings) PLC | -94.63% |